宝ホ
ン
連結
Takara Holdings Inc.
‐
Consolidated
‐
要約損益計算書
Consolidated Statements of Income by Business Group (Summary)
要約
借対照表
Consolidated Balance Sheets (Summary)
宝酒造
Takara Shuzo Group
要約損益計算書
Statements of Income (Summary)
要約
借対照表
Balance Sheets (Summary)
バ
Takara Bio Group
要約損益計算書
Statements of Income (Summary)
要約
借対照表
Balance Sheets (Summary)
成
期 参考資料
Reference Data for the Year Ended March 31, 2017
間
Six-Year Financial Summary by Business Group
成
日 発表
業績予想数値
比較
Change from forecast anounced Jan. 30, 2017
.
成
期 業績予想
Financial forecast for the year ending March 31, 2018
宝ホ
ン
連結
Takara Holdings Inc.
‐
Consolidated
‐
宝酒造
Takara Shuzo Co.,Ltd.
宝酒造 ン
Takara Shuzo International Group
バ
Takara Bio Group
成
期 参考資料
Reference Data for the year ending March 31, 2018
FAX 075(241)5194
E-Mail [email protected]
成
期
決算短信補足資料
IR部
Investor Relations Dept.
TEL 075(241)5124
将来見通
関す 注意事項
資料中 当社
び当社
現
計画 見通
戦略 確信
う
歴史的事実
いも
将来 業績 関す 見通
あ
現時
い 入手可能 情報
得
当社経営
断 基
くも
す
重大
や
確実性 含
い 情報
得
多く 仮定
び考え 基
も
あ
す 実際 業績
要素
予測
大 く異
結果
得
知
く
い
実際 業績 影響
え 要素
経済情勢 特 消費動向
替
変動 法
行政制度 変
競合会社 価格 製品戦略
力 当社 既存製品
び新製品 販売力
生産中断 当社 知
的所
権 対す 侵害 急速
術革新 重大
訟
け
利
決等 あ
す
業績 影響
え
要素
限定
も
あ
せ
宝ホールデ ン ス株式会社 IR部
Takara Holdings Inc. Investor Relations Dept.
T
7
X 7
9
a r ta ara c
Forward-Looking Statements
Statements in this document, other than those based on historical fact, concerning the current plans, prospects, strategies and
expectations of the Company and its Group represent forecasts of future results. While such statements are based on the
conclusions of management according to information available at the time of writing, they reflect many assumptions and opinions
derived from information that includes major risks and uncertainties. Actual results may vary significantly from these forecasts due to
various factors.
宝ホ
ン
連結
:Takara Holdings Inc. ‐Consolidated‐要約損益計算書
:Consolidated Statements of Income by Business Group (Summary)百万 :Millions of Yen
成
期
FY2016
実績
予想
実績
増減 比 増減 比Actual Forecast announced Actual Change % Difference % (a) Nov. 10, 2016 (b) (c) (c-a) (c/a) (c-b) (c/b)
宝酒造
バ
宝
そ 他
売
高
売
原価
売
総利益
運
費 保管料
広告宣伝費
研究開発費
管理費 そ 他
販売費及び一般管理費
宝酒造
バ
宝
そ 他
営業利益 △:損失
営業外収益
営業外費用
経常利益 △:損失
特
利益
特
損失
法人税
民税及び事業税
法人税等調整額
設備投資額
形 無形
減価償却費
形 無形
償却額
営業利益 経常利益 親会社株主 帰属す 当期純利益 成 期通期業績予想 修正 す p 参照 The Company revised FY2017 forecasts concerning Operating income, Ordinary income and Net income attributable to owners of the parent on January 30, 2017. (c.f. p13.)
営業外収益 利息 郤当金 持分法 投資利益 補助金収入
Non-operating income Interest income 193, Dividends income 465, Equity in earnings of affiliates 268, Subsidy income 288, etc. 営業外費用 支払利息 社債利息
Non-operating expenses Interest expense 224, Interest on bonds 257, etc. 特 利益 段階 得 差益 固定資産売却益
Extraordinary income Gain on step acquisitions 878, Gain on sales of noncurrent assets 206 etc. 特 損失 減損損失 固定資産 売却損
Extraordinary loss Impairment loss 667, Loss on sales and retirement of noncurrent assets 264, etc.
447 550
481
34 107.7% ᇞ 68 87.6%Interest and discounts expenses
そ 他営業外費用
223 150262
39 117.6% 112 175.3%Other, net
747 650
659
ᇞ 87 88.2% 9 101.5%Interest and Dividends income
1,082 750
878
ᇞ 204 81.1% 128 117.1%Other, net
利息 郤当金
そ 他営業外収益
Takara Shuzo Group
Cost of sales Gross profit Other, net Takara Bio Group
Net sales
Sales promotion and allowance for s.p.
販売
進費 販売
進引当金繰入
Operating income(∆:loss) Research and development Transportation and storage
Other, net Advertising
SG&A expenses Takara Shuzo Group Takara Bio Group
Other, net
Takara Healthcare Inc.
税金等調整前当期純利益 △:損失
Net income attributable to the noncontrolling interest(∆:loss) Income before income taxes(∆:loss) Non-operating income
Non-operating expenses Ordinary income(∆:loss)
支払利息
当期純利益 △:損失
Net income(∆:loss) Extraordinary income Extraordinary loss
Current income taxes Deferred income taxes
755
41 105.9%336 103.8%
Net income attributable to owners of the parent(∆:loss)
713
74
135 -ᇞ 60
親会社株主 帰属す 当期純利益 △:損失
5,208
369 107.6% 12,548700
7,769 8,900
9,236
1,466 118.9% 4,8004,839
353 176 118.6%
106.0% 13,700
400 172.9% 550
14,520
1,971 115.7%644
950
306 147.5%820 671
950
14,344
1,504 111.7%951 107.6% 12,600
744
73 111.0%13,551
1,870 116.0%44
137 109.8% 1,400
1,044 107.9% 13,300
1,126
773 318.9% 538 2,667 41 107.7% 555 7,055 8,410 35,000 4,700 29,700 77,815 2,850 1,830 11,680 12,840 2804,550
29,673
100 4801,537
ᇞ 292 84.0%580
ᇞ 1,241 98.5%
81,700 103.4%
8,480
1,425 120.2%120.9% 106.0% 9,200
3,202
535 120.1% 352 112.4%9,755
1,345 116.0%106.4% 700
55 108.0% 483 110.1%
80,458
2,643ᇞ 166
821
ᇞ 58
1,986 102.5% 98.7% 107.2% 60 100.7% 8,682 95.0% 96.9% 98.0% 99.9% 96.8%
ᇞ 101
ᇞ 707
ᇞ 149
ᇞ 26 234,100 139,800
234,193
3,365 33,471 4,608 27,686 3,3003,198
34,292
192,025 29,729 1,7441,879
9,146ᇞ 353
135
201,171
29,375
2,000
1,865 1,900
1,766
ᇞ 99100.0% 94.0%
382
ᇞ 120
93
97.2% 99.7%
ᇞ 289 107.8%
64 70
12
ᇞ 51 19.7% ᇞ 57 18.2%Takara Healthcare Inc.
225,364
94,300
140,182
94,010
4,514 105.0%135,868 4,314 103.2%
103.9% 8,829
89,495
8,743
9,000 ᇞ 256
100.3%
Amortization of goodwill
非支郤株主 帰属す 当期純利益 △:損失
Capital expenditures 6,003
6,658
654 110.9%ᇞ 28 99.5% 5,200
Depreciation and Amortization 5,179
5,171
ᇞ 8 99.8%103.4% 8,200
20 100.3% 6,638
成
期
対前期 対 予想Change from FY2016 Change from forecast anounced Nov. 2016 FY2017 / Apr. 1, 2016 - Mar. 31, 2017
538 460
586
47 108.8% 126 127.5%94.7% ᇞ 133 93.0% 104.8%
98.8%
99.8% 201,600
28,600
ᇞ 428
775 102.7%
要約
借対照表
:Consolidated Balance Sheets (Summary)
資産の部
:Assets百万
:Millions of Yen成
成
期
期
As of Mar. 31, 2016 As of Mar. 31, 2017 Change Reference
流動資産
(Total current assets)億 :One hundred millions of Yen
現金及び預金
H+ + +Cash and deposits
手形及び売掛金
+Notes and accounts receivable-trade
価証券
H△ △Marketable securities
卸資産
+Inventories
そ 他
Other current assets
倒引当金
Allowance for doubtful accounts
固定資産
(Total fixed assets)形固定資産
[Property, plant and equipment]
建物及び構築物
当期 形 無形固定資産 増減Buildings and structures Reference of Property, plant and equipment and Intangible assets
機械装置及び運搬具
新規 得 + + +Machinery, equipment and vehicles Newly purchases +66.5
土地
減価償却 △ △ △Land Depreciation ∆51.7
そ 他
そ 他増減 +Other property, plant and equipment Other, net +38.6
無形固定資産
[Intangible fixed assets]Goodwill
そ 他
Other intangible fixed assets
投資そ 他 資産
[Investments and other assets]投資
価証券
H+ △Investment securities
そ 他
Other assets倒引当金
Allowance for doubtful accounts
資産合計
Total assets(TH=Takara Holdings Inc., TS=Takara Shuzo Group, TB=Takara Bio Group)
増減
主 増減理由
173,912
159,073
14,839
58,073
38,386
19,686
57,951
53,602
4,349
13,237
28,238
ᇞ
15,000
39,851
34,218
5,632
5,035
4,859
175
ᇞ
236
ᇞ
231
ᇞ
5
100,456
94,179
6,276
59,174
53,065
6,108
20,952
17,735
3,216
12,315
12,554
ᇞ
239
20,089
18,118
1,970
5,816
4,656
1,160
10,256
11,010
ᇞ
754
31,025
30,103
922
6,975
6,626
ᇞ
349
4,035
3,630
ᇞ
405
25,583
24,747
835
274,368
253,253
21,115
5,533
5,468
64
ᇞ
90
要約
借対照表
:Consolidated Balance Sheets (Summary)
負債及び純資産
の部
:Liabilities and net assets百万
:Millions of Yen成
成
期
期
As of Mar. 31, 2016 As of Mar. 31, 2017 Change Reference
流動
債
(Total current liabilities)億 :One hundred millions of Yen
支払手形及び
掛金
+Notes and accounts payable-trade
短期借入金
+Short-term loans payable
1
償還 社債
H+Current portion of bonds 第9回普通社債 7年9月償還 第 回普通社債 7年 月償還
#9SB (Redemption, Sept. 2017) #12SB (Redemption, Apr. 2017)
払酒税
Accrued alcohol tax
払費用
+Accrued expenses
販売
進引当金
そ 他
Other current liabilities
固定
債
(Total non-current liabilities)
社債
H△Bonds payable 第9回普通社債 7年9月償還 第 回普通社債 7年 月償還
#9SB (Redemption, Sept. 2017) #12SB (Redemption, Apr. 2017)
長期借入金
Long-term loans payable
職給付
債
Net defined benefit liability
預 金
Deposits from customers
そ 他
Other non-current liabilities
債合計
Total liabilities資
金
Capital stock資
剰余金
Capital surplus利益剰余金
Retained earnings自己株式
Treasury stock株主資
(Total owner's equity)
そ 他
価証券評価差額金
H+繰延
ッ 損益
替換算調整
定
△ △USD=116.53JPY, EUR=122.73JPY, GBP=143.06JPY (Dec. 2016) USD=120.54JPY, EUR=131.67JPY, GBP=178.60JPY (Dec. 2015)
職給付
調整累計額
そ 他 包括利益累計額
非支郤株主持分
+(Noncontrolling interests)
純資産合計
Total net assets債純資産合計
Total liabilities and net assets(TH=Takara Holdings Inc., TS=Takara Shuzo Group, TB=Takara Bio Group)
ᇞ
264
Remeasurements of defined benefit plans増減
主 増減理由
274,368
253,253
21,115
30,877
25,762
5,115
165,920
156,148
9,771
1,650
1,879
ᇞ
229
119,729
113,663
5,836
ᇞ
9,939
0
124,667
ᇞ
9,938
ᇞ
0
6,066
118,830
ᇞ
445
Reserve for sales promotion expenses13,226
13,226
-
108,447
97,104
11,343
5,342
5,379
ᇞ
36
20,000
ᇞ
10,000
10,996
10,255
7,640
5,277
(Total valuation and translation adjustments)
445
9,583
6,822
2,760
11,555
ᇞ
1,179
Valuation difference on available-for-sale securities
Deffered gains or losses on hedges
Translation adjustments
5,548
1,426
ᇞ
4,122
10,375
ᇞ
370
ᇞ
634
2,362
741
8,544
8,961
416
5,562
4,965
597
1,899
1,870
29
10,000
7,593
7,855
ᇞ
261
4,994
4,212
10,000
-
10,000
9,206
14,439
12,760
1,678
42,941
49,456
ᇞ
6,514
65,506
47,648
17,858
16,804
15,201
1,603
宝酒造
:Takara Shuzo Group要約損益計算書
:Statements of Income (Summary)百万
:Millions of Yen成
期
Y
実績
予想
実績
増減
比
増減
比
Actual Forecast Actual Change % Difference % (a) Nov. 10, 2016 (b) (c) (c-a) (c/a) (c-b) (c/b)
焼郥
清酒
ソ
コ
飲料
そ 他酒類
そ 他調味料
原料用
コ
等
海外日
食材卸
そ 他
売
高
売
原価
売
総利益
運
費 保管料
広告宣伝費
研究開発費
管理費 そ 他
販売費及び一般管理費
営業利益 △:損失
営業外収益
営業外費用
経常利益 △:損失
特
利益
特
損失
法人税
民税及び事業税
法人税等調整額
営業利益 経常利益 親会社株主 帰属す 当期純利益 成 期通期業績予想 修正 す p 参照
The Company revised FY2017 forecasts concerning Operating income, Ordinary income and Net income attributable to owners of the parent on January 30, 2017. (c.f. p13.)
設備投資額
形 無形
減価償却費
形 無形
償却額
99.8%
96.4%
102.9%
ᇞ
280
101.2%
104.5%
ᇞ
858
98.9%
97.5%
ᇞ
428
96.6%
ᇞ
662
9,146
15
71,138
192,025
Transportation and storage
8,300
2,700
87.9%
32,405
329
104.7%
33,337
344
104.8%
201,600
125,900
5,442
2,723
7,924
103.6%
7,500
Raw alcohol
7,197
7,771
573
108.0%
12,300
Other
13,641
11,987
ᇞ
1,653
ᇞ
312
20,668
26,800
28,933
8,265
140.0%
2,133
108.0%
Japanese food wholesale business in overseas markets
99.7%
3,200
110.7%
2,952
ᇞ
8
317
107.4%
ᇞ
101
931
1,417
97.9%
103.4%
6,700
ᇞ
1,413
97.9%
103.8%
1,453
126.5%
102.6%
ᇞ
55
100.9%
98.1%
86.1%
23
97.7%
100.3%
ᇞ
803
110.7%
97.8%
59,300
25,200
成
期
ᇞ
1,298
ᇞ
377
対前期
対
予想
FY2017 / Apr. 1, 2016 - Mar. 31, 2017 Change from FY2016
98.5%
Change from forecast anounced Nov. 201697.5%
ᇞ
1,374
85
2,981
100.8%
75,700
126,329
74,841
3,703
105.2%
429
99.6%
14,116
ᇞ
53
9,749
435
116
100.3%
98.6%
15,200
100.5%
104.7%
49
9,700
ᇞ
113
99.2%
ᇞ
208
271
125
601
79.4%
2,358
95
66,500
5,474
ᇞ
156
10
8,019
2,824
34,000
400
21,100
6,927
441
8,570
124
5,663
2,781
19,244
65,086
20,661
62,728
8,410
9,755
1,345
8,726
100
925
839
1077.7%
85
757
114.0%
546
105.8%
116.0%
410
555
ᇞ
31
92.9%
9,400
1
10
400
ᇞ
438
200
394
112.3%
3,200
2
ᇞ
122
1.8%
ᇞ
0
199
6,900
7,126
1,463
125.8%
226
103.3%
3,592
810
129.1%
106.0%
9,200
9,946
1,220
Other, net Advertising
Sales promotion and allowance for s.p.
販売
進費 販売
進引当金繰入
Operating income(∆:loss) Research and development
10,721
2,151
125.1%
115.7%
800
151
ᇞ
91
62.3%
242
51
151.1%
621
106.2%
10,100
100.2%
600
SG&A expenses
親会社株主 帰属す 当期純利益 △:損失
Extraordinary gain
Extraordinary loss
Current income taxes
Deferred income taxes
税金等調整前当期純利益 △:損失
Net income attributable to the noncontrolling interest(∆:loss) Income before income taxes(∆:loss) Non-operating income
Non-operating expenses
Ordinary income(∆:loss)
当期純利益 △:損失
Net income(∆:loss) ShochuCost of sales
Gross profit
Light-alcohol refreshers Sake
Net sales
Other liquors
14,000
14,991
14,170
59,376
24,736
27,815
31,600
30,796
201,171
120,886
58,001
24,822
Hon Mirin9,314
Other seasonings15,104
357
280
424
66
118.6%
144
151.4%
Amortization of goodwill
非支郤株主 帰属す 当期純利益 △:損失
Net income attributable to owners of the parent(∆:loss)
105.4%
189
227
Capital expenditures
2,919
3,269
349
112.0%
Depreciation and Amortization
3,252
3,191
ᇞ
60
98.1%
要約
借対照表
:Balance Sheets (Summary)
資産の部
:Assets百万
:Millions of Yen成
成
期
期
As of Mar. 31, 2016 As of Mar. 31, 2017 Change Reference
流動資産
(Total current assets)億 :One hundred millions of Yen
現金及び預金
ミ ィ ク +Cash and deposits Mutual Trading +32.1
手形及び売掛金
ミ ィ ク +Notes and accounts receivable-trade Mutual Trading +33.9
価証券
Marketable securities卸資産
ミ ィ ク +Inventories Mutual Trading +49.1
そ 他
Other current assets
倒引当金
Allowance for doubtful accounts
固定資産
(Total fixed assets)形固定資産
[Property, plant and equipment]
建物及び構築物
当期 形 無形固定資産 増減Buildings and structures Reference of Property, plant and equipment and Intangible assets
機械装置及び運搬具
新規 得 +Machinery, equipment and vehicles Newly purchases +32.6
土地
減価償却 △Land Depreciation ∆31.9
そ 他
そ 他増減 +Other property, plant and equipment Other, net +52.7
無形固定資産
[Intangible fixed assets]Goodwill
そ 他
Other intangible fixed assets
投資そ 他 資産
[Investments and other assets]投資
価証券
ミ ィ ク 社 連結子会社 投資 消去 △Investment securities Elimination of investment securities resulting from the conversion of Mutual Trading into a new consolidated subsidiary △3,052
そ 他
Other assets
倒引当金
Allowance for doubtful accounts
資産合計
Total assets3,541
6,393
ᇞ
2,852
166,697
150,773
15,924
3,842
3,872
ᇞ
29
ᇞ
43
ᇞ
58
14
7,541
7,992
ᇞ
451
7,340
10,208
ᇞ
2,867
5,334
5,412
78
2,658
2,129
ᇞ
529
9,229
6,991
2,238
2,923
2,023
900
11,781
8,964
2,817
9,894
10,010
ᇞ
116
48,711
46,191
2,519
33,829
27,990
5,838
4,870
4,769
101
ᇞ
204
ᇞ
188
ᇞ
15
10,237
10,516
ᇞ
278
34,184
28,962
5,221
18,873
14,321
4,551
50,025
46,201
3,824
増減
主 増減理由
117,986
104,582
13,404
要約
借対照表
:Balance Sheets (Summary)負債及び純資産
の部
:Liabilities and net assets百万
:Millions of Yen成
成
期
期
As of Mar. 31, 2016 As of Mar. 31, 2017 Change Reference
流動
債
(Total current liabilities)億 :One hundred millions of Yen
支払手形及び
掛金
ミ ィ ク +Notes and accounts payable-trade Mutual Trading +11.5
短期借入金
ミ ィ ク + 宝酒造 +Short-term loans payable Mutual Trading +43.9, Takara Shuzo +10.0
払酒税
Accrued alcohol tax払費用
ミ ィ ク +Accrued expenses Mutual Trading +7.4
販売
進引当金
そ 他
Other current liabilities
固定
債
(Total non-current liabilities)
長期借入金
Long-term loans payable
職給付
債
Net defined benefit liability
預 金
Deposits from customers
そ 他
Other non-current liabilities
債合計
Total liabilities資
金
Capital stock資
剰余金
宝酒造△Capital surplus Takara Shuzo △25.2
利益剰余金
Retained earnings株主資
(Total owner's equity)
そ 他
価証券評価差額金
繰延
ッ 損益
替換算調整
定
xc an e ateUSD=116.53JPY, EUR=122.73JPY, GBP=143.06JPY (Dec. 2016) USD=120.54JPY, EUR=131.67JPY, GBP=178.60JPY (Dec. 2015)
職給付
調整累計額
そ 他 包括利益累計額
非支郤株主持分
ミ ィ ク +(Noncontrolling interests) Mutual Trading +41.3
純資産合計
Total net assets債純資産合計
Total liabilities and net assetsᇞ
3,460
Translation adjustments7,601
7,870
268
5,169
ᇞ
2,752
36,279
29,351
6,927
50,109
52,861
4,907
ᇞ
261
4,040
867
1,899
1,870
29
ᇞ
144
ᇞ
3,026
87,388
83,213
4,175
0
ᇞ
445
445
132
567
435
3,654
193
7,380
2,239
5,141
166,697
150,773
15,924
95,170
88,880
6,289
48,687
40,948
7,739
13,719
12,300
1,419
10,918
5,642
5,276
7,593
7,855
9,648
9,238
409
22,840
20,944
1,895
6,793
6,319
474
Remeasurements of defined benefit plans
(Total valuation and translation adjustments)
3,427
400
ᇞ
361
ᇞ
217
増減
主 増減理由
Reserve for sales promotion expenses
Valuation difference on available-for-sale securities
Deffered gains or losses on hedges
71,527
61,893
9,634
1,000
1,000
-
5,219
ᇞ
50
3,006
バ
:Takara Bio Group要約損益計算書
:Statements of Income (Summary)百万
:Millions of Yen成
期
Y
実績
予想
実績
増減
比
増減
比
Actual Forecast Actual Change % Difference % (a) Nov. 19, 2016 (b) (c) (c-a) (c/a) (c-b) (c/b)
研究用試薬
理
学機器
そ 他
バ
産業支援 計
遺伝子医療
医食品バ
売
高
売
原価
売
総利益
運
費 保管料
広告宣伝費
研究開発費
管理費 そ 他
販売費及び一般管理費
遺伝子医療
医食品バ
共通
営業利益 △:損失
営業外収益
営業外費用
経常利益 △:損失
特
利益
特
損失
法人税
民税及び事業税
法人税等調整額
売 高 営業利益 経常利益 成 期通期業績予想 修正 す p 参照
The Company revised FY2017 forecasts concerning Net sales, Operating income and Ordinary income on January 30, 2017. (c.f. p13.)
設備投資額
形 無形
減価償却費
形 無形
償却額
ᇞ
747
2,301
104
ᇞ
6
94.1%
110
ᇞ
1
669
13,688
13,655
61
ᇞ
1,773
6,218
6,138
13,749
93
100.7%
ᇞ
1,380
393
-
79
101.3%
69
-
Research reagents
Cost of sales
Gross profit
Contracted service and other Scientific instruments
Net sales
Transportation and storage
Other, net Advertising
Sales promotion
販売
進費
Research and development Bioindustry
Gene Therapy
AgriBio
Net income attributable to owners of the parent(∆:loss) SG&A expenses
親会社株主 帰属す 当期純利益 △:損失
Extraordinary income
Extraordinary loss
Current income taxes
Deferred income taxes
税金等調整前当期純利益 △:損失
Net income attributable to the noncontrolling interest(∆:loss) Income before income taxes(∆:loss) Non-operating income
Non-operating expenses
Ordinary income(∆:loss) Operating income(∆:loss) Bioindustry
Gene Therapy
Eliminations/Corporate
バ
産業支援
当期純利益 △:損失
Net income(∆:loss) AgriBio101.4%
642
69
4
352
112.4%
3,301
429
102.2%
2
2,667
8
ᇞ
6
ᇞ
1
62.5%
113.6%
3,150
60
852.4%
2
91.3%
3,579
277
ᇞ
1,808
ᇞ
106
112.8%
10
103.0%
102.7%
89
854
ᇞ
33
ᇞ
117
ᇞ
13
ᇞ
47
101.9%
102.5%
594
500
500
-
87.1%
72.6%
87.9%
94.7%
500
-
378
13,405
12,061
ᇞ
983
92.7%
399
380
395
203.9%
108.4%
-
ᇞ
2,049
ᇞ
55
65.1%
160
0
2,850
3,202
535
118.6%
375
120.1%
-
ᇞ
1,737
ᇞ
1,739
2,200
Capital expenditures
1,648
ᇞ
441
100.2%
1,350
445
ᇞ
196
69.4%
68
2,905
33
101.2%
5
2,771
ᇞ
88
83.1%
3
31
102.2%
1,417
ᇞ
43
75
775
376
194.2%
1,334
2
1,492
ᇞ
160
90.3%
1,653
44
1,340
-
96.6%
1,353
59.4%
ᇞ
0
3
ᇞ
2
2,805
ᇞ
99
28,600
629
103.9%
ᇞ
174
286
103.7%
95.9%
8,110
29,375
360
対前期
対
予想
FY2017 / Apr. 1, 2016 - Mar. 31, 2017 Change from FY2016 Change from forecast anounced Nov. 2016
775
2,404
26,195
99.6%
19,515
2,663
成
期
ᇞ
78
247
19,436
2,911
98.8%
109.3%
95.6%
ᇞ
102
95.7%
ᇞ
353
105.2%
209
100.5%
2,408
1,356
16
101.2%
2
100.2%
901
4,275
7,824
971
4,275
7,654
4,101
ᇞ
174
456
ᇞ
37
94.1%
414
ᇞ
258
96.0%
6,476
16,538
12,422
122
95.9%
106.0%
27,320
632
16,323
584
102
94.9%
-
-
16,952
29,729
20,488
3,087
3,744
97.3%
4,015
4,225
94.3%
ᇞ
1,051
ᇞ
176
480
26,573
181
159
162
ᇞ
18
89.6%
3
102.0%
Amortization of goodwill
非支郤株主 帰属す 当期純利益 △:損失
1,352
18
101.4%
ᇞ
31
2,090
98.2%
1,753
74.9%
78.9%
Depreciation and Amortization
1,687
1,722
34
102.0%
ᇞ
551
要約
借対照表
:Balance Sheets (Summary)
資産の部
:Assets百万
:Millions of Yen成
成
期
期
As of Mar. 31, 2016 As of Mar. 31, 2017 Change Reference
流動資産
(Total current assets)億 :One hundred millions of Yen
現金及び預金
ホ ィ ク バ △Cash and deposits Takara Bio USA Holdings +139.2, Takara Bio △57.4
手形及び売掛金
Notes and accounts receivable-trade
価証券
バ △Marketable securities Takara Bio △69.9
卸資産
Inventoriesそ 他
Other current assets
倒引当金
Allowance for doubtful accounts
固定資産
(Total fixed assets)形固定資産
[Property, plant and equipment]
建物及び構築物
当期 形 無形固定資産 増減Buildings and structures Reference of Property, plant and equipment and Intangible assets
機械装置及び運搬具
新規 得 +Machinery, equipment and vehicles Newly purchases +16.4
土地
減価償却 △Land Depreciation ∆17.2
そ 他
そ 他増減 △Other property, plant and equipment Other, net △12.7
無形固定資産
[Intangible fixed assets]Goodwill
そ 他
Other intangible fixed assets
投資そ 他 資産
[Investments and other assets]長期前払費用
Long-term prepaid expenses
そ 他
Other assets倒引当金
Allowance for doubtful accounts
資産合計
Total assets43,964
42,158
1,806
28,078
19,384
8,693
7,455
6,830
625
2,000
9,721
ᇞ
7,721
5,462
5,100
362
998
1,163
ᇞ
164
ᇞ
30
ᇞ
41
11
23,178
24,432
ᇞ
1,254
19,577
20,534
ᇞ
957
7,667
8,207
ᇞ
540
2,349
2,461
ᇞ
111
7,297
7,696
ᇞ
398
ᇞ
165
2,263
2,170
93
2,301
2,695
ᇞ
394
1,641
1,213
ᇞ
427
1,054
1,087
33
増減
主 増減理由
67,143
66,591
552
454
192
262
ᇞ
11
ᇞ
11
-
1,299
1,202
97
要約
借対照表
:Balance Sheets (Summary)
負債及び純資産
の部
:Liabilities and net assets百万
:Millions of Yen成
成
期
期
As of Mar. 31, 2016 As of Mar. 31, 2017 Change Reference
流動
債
(Total current liabilities)億 :One hundred millions of Yen
支払手形及び
掛金
Notes and accounts payable-trade短期借入金
Short-term loans payable
そ 他
Other current liabilities
固定
債
(Total non-current liabilities)
長期借入金
Long-term loans payable
職給付
債
Net defined benefit liability
そ 他
Other non-current liabilities
債合計
Total liabilities資
金
Capital stock資
剰余金
Capital surplus利益剰余金
Retained earnings株主資
(Total owner's equity)
替換算調整
定
xc an e ateUSD=116.53JPY, EUR=122.73JPY, GBP=143.06JPY (Dec. 2016) USD=120.54JPY, EUR=131.67JPY, GBP=178.60JPY (Dec. 2015)
職給付
調整累計額
そ 他 包括利益累計額
非支郤株主持分
(Noncontrolling interests)純資産合計
Total net assets債純資産合計
Total liabilities and net assets488
622
134
32,893
-
1,136
677
-
ᇞ
5
431
4,033
3,675
358
1,131
1,050
81
Translation adjustments
32,893
10,432
9,295
7,157
6,480
14,965
14,965
426
(Total valuation and translation adjustments)
2,852
1,593
2,023
3,109
ᇞ
1,086
ᇞ
1,258
ᇞ
257
ᇞ
429
ᇞ
172
Remeasurements of defined benefit plans253
47
63
ᇞ
16
67,143
66,591
552
59,985
60,110
ᇞ
124
130
82
ᇞ
47
増減
主 増減理由
100
102
ᇞ
2
58,291
57,155
1,136
6,025
5,430
595
1,944
1,690
成
期 参考資料
:Reference Data for the Year Ended March 31, 2017替前提及び売
高 対す
替
変動 影響
:Exchange rates and effect of change in exchange rates on net sales◆
替前提 海外子会社P
換算用
:Exchange rates for the income statement of oversea subsidiaries : Yen成
期
Y
実績
予想
実績
Actual Forecast announced Actual
前期差
予想差
(a) Nov. 10, 2016 (b) (c) Change(c-a) Difference(c-b)
121.11
106.40
108.81
ᇞ
12.30
2.41
185.20
146.10
147.64
ᇞ
37.56
1.54
134.31
118.60
120.30
ᇞ
14.01
1.70
19.23
16.10
16.36
ᇞ
2.87
0.26
10.71
9.10
9.37
ᇞ
1.34
0.27
1.89
1.59
1.62
ᇞ
0.27
0.03
14.36
12.60
12.72
ᇞ
1.64
0.12
88.25
77.70
78.76
ᇞ
9.49
1.06
◆売
高 対す
替
変動 影響額
:Effect of change in exchange rates on net sales百万
:Millions of Yen対前期
対
予想
Change from FY2016 Change from forecast anounced Nov. 2016
焼郥
Shochu
清酒
Sake
ソ
コ
飲料
Light-alcohol refreshers
そ 他酒類
Other liquors Hon Mirin
そ 他調味料
Other seasonings
原料用
コ
等
Raw alcohol
海外日
食材卸
Japanese food wholesale business in overseas markets
そ 他
Other
宝酒造
計
Net sales of Takara Shuzo Group
研究用試薬
Research reagents
理
学機器
Scientific instruments
そ 他
Contracted service and other
バ
産業支援 計
Bioindustry
遺伝子医療
Gene Therapy
医食品バ
AgriBio
バ
計
Net sales of Takara Bio Group
宝ホ
ン
計
海外売
高比率 推移
:Change in overseas sales ratio成
成
成
成
成
期
期
期
期
期
宝酒造
Takara Shuzo Group
バ
Takara Bio Group
そ 他
3
成
期
FY2017 / Apr. 1, 2016 - Mar. 31, 2017
米
US dollarン
Pound Euro人民元
Yuanウ ン
100 Wonン
Rupeeホ
Singapore dollarᇞ
23
ク
Sweden kronaᇞ
284
48
ᇞ
4
0
ᇞ
827
81
ᇞ
58
8
ᇞ
46
7
-
-
ᇞ
3,132
951
-
-
ᇞ
4,377
1,100
-
-
ᇞ
1,854
263
ᇞ
17
2
ᇞ
138
16
ᇞ
2,010
282
-
-
FY2017
50.4%
FY2013 FY201418.5%
15.7%
13.7%
8.9%
5.8%
54.2%
50.3%
45.9%
39.1%
FY2015 FY2016
ᇞ
2,010
282
-Consolidated-海外主要子会社 業績
:Financial Result of major overseas subsidiaries売
高
営業利益
売
高
営業利益
Net Sales Operating income(∆:loss) Net Sales Operating income(∆:loss)
千 :Thousands of US dollar 31,052 3,676 32,782 4,750
百 万 :Millions of Yen 3,760 445 3,567 516
千 元 :Thousands of Yuan 48,326 3,262 46,997 2,404
百 万 :Millions of Yen 929 62 768 39
千 ン :Thousands of Pound 15,576 3,091 14,509 3,364
百 万 :Millions of Yen 2,884 572 2,142 496
千 :Thousands of US dollar 17,173 6,256 20,479 7,774
百 万 :Millions of Yen 2,079 757 2,228 845
千 :Thousands of Euro 113,473 12,009 133,913 15,764
百 万 :Millions of Yen 15,240 1,612 16,109 1,896
千 ン :Thousands of Pound 29,513 2,868 34,481 1,995
百 万 :Millions of Yen 5,465 531 5,090 294
千 :Thousands of Euro 17,314 2,121 19,372 2,299
百 万 :Millions of Yen 2,325 284 2,330 276
千 :Thousands of Sweden Krona 27,314 ᇞ 16,576 28,009 ᇞ 15,329
百 万 :Millions of Yen 392 ᇞ 238 356 ᇞ 194
千 元 :Thousands of Yuan 291,253 125,143 305,664 124,340
百 万 :Millions of Yen 5,600 2,406 5,000 2,034
千 元 :Thousands of Yuan 96,756 ᇞ 1,650 135,179 3,737
百 万 :Millions of Yen 1,860 ᇞ 31 2,211 61
百 万 :Millions of Won 8,601 999 8,921 1,250
百 万 :Millions of Yen 921 107 835 117
千 :Thousands of Rupee 187,515 766 196,570 ᇞ 581
百 万 :Millions of Yen 354 1 318 ᇞ 0
千 :Thousands of US dollar 67,962 11,996 75,697 16,996
百 万 :Millions of Yen 8,230 1,452 8,236 1,849
宝酒造
営業利益増減要因
:Factors of change in operating income of Takara Shuzo Group 百万 :Millions of Yen対前期増減
対 予想増減Change from FY2016 Change from forecast anounced Nov. 2016
+1,345
+555
※利益 増加要因 減少要因 △ 表示 *An increasing factor and a decreasing factor on profit are shown + and △, respectively
成
期 実績
成
期 実績
FY2016 Actual FY2017 Actual
FOODEX Group
キ
TAZAKI FOODS LTD.
米国宝酒造
Takara Sake USA Inc.
宝酒造食品
Takara Shuzo Foods Co.,Ltd.
ン
The Tomatin Distillery Co.,Ltd. AGE INTERNATIONAL,INC.
ッ
Takara Bio Europe S.A.S. Takara Bio Europe AB
数量差 単価差
バ
ン
DSS Takara Bio India Private Limited
要因
容
Change in quantities +1,665 Change in unit price +574 Change in quantities △166 Change in unit price △1,364
宝生物工程 大連
Takara Biotechnology (Dalian) Co.,Ltd.
宝日医生物
術
京
Takara Biomedical Technology Beijing) Co., Ltd.
コ
メ ィ
Takara Korea Biomedical Inc.
容
数量差 単価差 数量差 △ 単価差 △
バ
Takara Bio USA, Inc.
TAKARA SHUZO CO.,LTD.
➣主 Breakdown
Factors Detail Detail
販売費及び一般管理費 増減
宝酒造単体
Change in SG&A expenses of TAKARA
SHUZO CO.,LTD. 販売 進費 減少
Change in Sales promotion and allowance for s.p. △984 Shochu △179 (Change in quantities △581 Change in unit price +402)
Sake +177 (Change in quantities +327 Change in unit price △149)
売
総利益 増減
宝酒造単体
Change in Gross profit of TAKARA SHUZO CO.,LTD.
ᇞ
1,236
ᇞ
1,530
+2,240
広告宣伝費 減少 Change in Advertising +72 焼郥△ 数量差△ 単価差 清酒 数量差 単価差△
Change in Advertising +40
+1,398
*Included in changes above ※ 数量差 び単価差 含
ᇞ
132
+1,003
Change in Sales promotion and allowance for s.p. +558 販売 進費 増加 △
宝酒造
計
Takara Shuzo Group
海外日 食材卸会社 ※ 償却
+688
運 費 増加 △ 運 費 減少
Light-alcohol refreshers +1,566( Change in quantities +1,394 Change in unit price +172)
Hon Mirin+113 (Change in quantities +2 Change in unit price +111) 数量差 単価差
Change in Transportation △302
宝酒造単体 計
参考 原価コ ウン ※ 数量差 び単価差 含 Reference :Cost reduction +417
参考 原価コ ウン △ Reference :Cost reduction △202
*Included in changes above
Change in Transportation +79 広告宣伝費 減少
Japanese food wholesale business in overseas markets +149
TAZAKI FOODS LTD. △0
Mutual Trading +26 *Include amortization of goodwill そ 他 海外子会社
そ 他 子会社
け
営業利益 増減
Change in Operating income of other subsidiaries
+341
Elimination of intra-company transactions,etc. △168 連結消去等 △
Domestic subsidiaries +76 国 子会社
Other overseas subsidiaries +63 そ 他 海外子会社
Mutual Trading +263 *Include amortization of goodwill
Foodex Group +303
Japanese food wholesale business in overseas markets +369
Other overseas subsidiaries +322 国 子会社
Domestic subsidiaries +79 連結消去等
Elimination of intra-company transactions,etc. +136
ャ ン ャ ン
Foodex Group +123
ッ キ △ ッ キ △
TAZAKI FOODS LTD. △196
海外日 食材卸会社 ※ 償却
間
:Six-Year Financial Summary by Business Group宝ホールデ ン ス 連結 :Takara Holdings Inc. -Consolidated- 百万 :Millions of Yen
成 成 成 成 成 成
期 期 期 期 期 期
増減 比
Change YOY% 198,690 200,989 209,568 219,490 225,364 234,193 8,829 103.9%
売 原価 Cost of sales 121,462 123,630 129,447 134,390 135,868 140,182 4,314 103.2%
売 高原価率 (Ratio to Net sales) 61.1% 61.5% 61.8% 61.2% 60.3% 59.9% -0.4pt -
77,228 77,359 80,121 85,099 89,495 94,010 4,514 105.0%
販売費及び一般管理費 SG&A expenses 67,963 68,225 70,631 74,003 77,815 80,458 2,643 103.4%
売 高販管費率 (Ratio to Net sales) 34.2% 33.9% 33.7% 33.7% 34.5% 34.4% -0.2pt -
9,264 9,133 9,490 11,096 11,680 13,551 1,870 116.0%
売 高営業利益率 (Ratio to Net Sales) 4.7% 4.5% 4.5% 5.1% 5.2% 5.8% +0.6pt -
32,436 32,838 32,954 32,818 33,471 34,292 821 102.5%
売 高販 費率 (Ratio to Net sales) 16.3% 16.3% 15.7% 15.0% 14.9% 14.6% -0.2pt -
3,027 3,090 3,376 3,754 4,608 4,550 ᇞ 58 98.7%
売 高研究開発費率 (Ratio to Net sales) 1.5% 1.5% 1.6% 1.7% 2.0% 1.9% -0.1pt -
5,330 5,282 8,967 9,533 6,003 6,658 654 110.9%
4,431 4,251 4,287 4,662 5,179 5,171 ᇞ 8 99.8%
271 267 348 500 538 586 47 108.8%
宝酒造 ルー :Takara Shuzo Group 百万 :Millions of Yen
成 成 成 成 成 成
期 期 期 期 期 期
増減 比
Change YOY% 175,503 176,946 182,306 190,089 192,025 201,171 9,146 104.8%
売 原価 Cost of sales 110,454 112,384 116,619 120,691 120,886 126,329 5,442 104.5%
売 高原価率 (Ratio to Net sales) 62.9% 63.5% 64.0% 63.5% 63.0% 62.8% -0.2pt -
65,049 64,562 65,686 69,397 71,138 74,841 3,703 105.2%
販売費及び一般管理費 SG&A expenses 58,280 58,174 59,357 61,556 62,728 65,086 2,358 103.8%
売 高販管費率 (Ratio to Net sales) 33.2% 32.9% 32.6% 32.4% 32.7% 32.4% -0.3pt -
6,768 6,387 6,329 7,840 8,410 9,755 1,345 116.0%
売 高営業利益率 (Ratio to Net sales) 3.9% 3.6% 3.5% 4.1% 4.4% 4.8% +0.5pt -
31,433 31,815 31,889 31,818 32,405 33,337 931 102.9%
売 高販 費率 (Ratio to Net sales) 17.9% 18.0% 17.5% 16.7% 16.9% 16.6% -0.3pt -
2,743 2,529 2,954 4,594 2,919 3,269 349 112.0%
3,225 2,997 2,968 3,170 3,252 3,191 ᇞ 60 98.1%
146 148 217 363 357 424 66 118.6%
タ ラバ ルー :Takara Bio Group 百万 :Millions of Yen
成 成 成 成 成 成
期 期 期 期 期 期
増減 比
Change YOY% 19,578 20,564 23,905 25,969 29,729 29,375 ᇞ 353 98.8%
売 原価 Cost of sales 9,194 9,540 11,331 12,142 13,405 12,422 ᇞ 983 92.7%
売 高原価率 (Ratio to Net sales) 47.0% 46.4% 47.4% 46.8% 45.1% 42.3% -2.8pt -
10,383 11,024 12,574 13,827 16,323 16,952 629 103.9%
販売費及び一般管理費 SG&A expenses 8,836 9,332 10,619 11,524 13,655 13,749 93 100.7%
売 高販管費率 (Ratio to Net sales) 45.1% 45.4% 44.4% 44.4% 45.9% 46.8% +0.9pt -
1,547 1,691 1,954 2,302 2,667 3,202 535 120.1%
売 高営業利益率 (Ratio to Net sales) 7.9% 8.2% 8.2% 8.9% 9.0% 10.9% +1.9pt -
2,658 2,715 3,026 3,401 4,275 4,101 ᇞ 174 95.9%
売 高研究開発費率 (Ratio to Net sales) 13.6% 13.2% 12.7% 13.1% 14.4% 14.0% -0.4pt -
926 2,397 5,538 4,762 2,090 1,648 ᇞ 441 78.9%
1,077 1,104 1,157 1,347 1,687 1,722 34 102.0%
124 119 131 136 181 162 ᇞ 18 89.6%
宝 ルス :Takara Healthcare Inc. 百万 :Millions of Yen
成 成 成 成 成 成
期 期 期 期 期 期
増減 比
Change YOY% 2,338 2,008 1,424 1,652 1,865 1,766 ᇞ 99 94.7%
売 原価 Cost of sales 1,492 1,233 674 803 893 669 ᇞ 223 74.9%
売 高原価率 (Ratio to Net sales) 63.8% 61.4% 47.4% 48.6% 47.9% 37.9% -10.0pt -
845 774 749 848 972 1,097 124 112.8%
販売費及び一般管理費 SG&A expenses 960 797 728 810 907 1,084 176 119.5%
売 高販管費率 (Ratio to Net sales) 41.1% 39.7% 51.1% 49.1% 48.6% 61.4% +12.7pt - ᇞ 114 ᇞ 22 21 38 64 12 ᇞ 51 19.7%
売 高営業利益率 (Ratio to Net sales) - - 1.5% 2.3% 3.5% 0.7% -2.7pt -
1,220 1,265 1,424 1,652 1,865 1,766 ᇞ 99 94.7%
前期対比
Change from FY2016
FY2017
売 高 Net sales
FY2012 FY2013 FY2014 FY2015 FY2016
売 総利益 Gross profit
営業利益 △:損失 Operating income(∆:loss)
販売 進費 販売 進引当金繰入Sales promotion and allowance for s.p.
研究開発費 R&D expenses
設備投資額 形 無形 Capital expenditures
減価償却費 形 無形 Depreciation and Amortization
前期対比
Change from FY2016
FY2012 FY2013 FY2014 FY2015 FY2016 FY2017
売 高 Net sales
売 総利益 Gross profit
営業利益 △:損失 Operating income(∆:loss)
販売 進費 販売 進引当金繰入Sales promotion and allowance for s.p.
設備投資額 形 無形 Capital expenditures
減価償却費 形 無形 Depreciation and Amortization
営業利益 △:損失 Operating income(∆:loss)
前期対比
Change from FY2016
FY2012 FY2013 FY2014 FY2015 FY2016 FY2017
前期対比
Change from FY2016
FY2012 FY2013 FY2014 FY2015 FY2016 FY2017
設備投資額 形 無形
売 高 Net sales
売 総利益 Gross profit
営業利益 △:損失 Operating income(∆:loss)
事業売 高 Net sales of Healthcare products
償却額 Amortization of goodwill
償却額 Amortization of goodwill
償却額 Amortization of goodwill
研究開発費 R&D expenses
設備投資額 形 無形 Capital expenditures
減価償却費 形 無形 Depreciation and Amortization
売 高 Net sales
成
日 発表
業績予想数値
比較
:Change from forecast anounced Jan. 30, 2017宝ホ
ン
連結
:
Takara Holdings Inc.-Consolidated-百万 :Millions of Yen
成
期
FY2016
実績
予想
実績
増減 比 増減 比Actual Forecast announced Actual Change % Difference % (a) Jan. 30, 2017 (b) (c) (c-a) (c/a) (c-b) (c/b)
売
高
営業利益 △:損失
経常利益 △:損失
宝酒造
Takara Shuzo Group百万 :Millions of Yen
成
期
FY2016
実績
予想
実績
増減 比 増減 比Actual Forecast announced Actual Change % Difference % (a) Jan. 30, 2017 (b) (c) (c-a) (c/a) (c-b) (c/b)
売
高
営業利益 △:損失
経常利益 △:損失
バ
Takara Bio Group百万 :Millions of Yen
成
期
FY2016
実績
予想
実績
増減 比 増減 比Actual Forecast announced Actual Change % Difference % (a) Jan. 30, 2017 (b) (c) (c-a) (c/a) (c-b) (c/b)
売
高
営業利益 △:損失
経常利益 △:損失
成
期
対前期 対 予想FY2017 / Apr. 1, 2016 - Mar. 31, 2017 Change from FY2016 Change from forecast anounced Jan. 2017
100.0%
Net sales
11,680 13,100
13,551
1,870 116.0% 451 103.4%Operating income(∆:loss)
225,364 234,100
234,193
8,829 103.9% 93103.9%
Ordinary income(∆:loss)
7,055 8,300
8,480
1,425 120.2% 180 102.2% Net income attributable to owners of the parent(∆:loss)12,840 13,800
14,344
1,504 111.7% 544101.9%
Operating income(∆:loss)
8,726 9,600
9,946
1,220 114.0%99.8%
Net sales
8,410 9,400
9,755
1,345 116.0% 355 103.8% 192,025 201,600201,171
9,146 104.8% ᇞ 428Operating income(∆:loss)
3,301 3,430
3,579
277275 100.9%
Net sales
2,667 3,100
3,202
535 120.1% 102 103.3% 29,729 29,10029,375
ᇞ 353 98.8%2 100.2% Net income attributable to owners of the parent(∆:loss)
108.4% 149 104.4%
Ordinary income(∆:loss)
親会社株主 帰属す 当期純利益 △:損失 1,334 1,350
1,352
18 101.4%対 予想 FY2017 / Apr. 1, 2016 - Mar. 31, 2017 Change from FY2016 Change from forecast anounced Jan. 2017 親会社株主 帰属す 当期純利益 △:損失
成
期
対前期 対 予想FY2017 / Apr. 1, 2016 - Mar. 31, 2017 Change from FY2016 Change from forecast anounced Jan. 2017
親会社株主 帰属す 当期純利益 △:損失
成
期
対前期Net income attributable to owners of the parent(∆:loss)
346 103.6%
Ordinary income(∆:loss)
5,474 6,800
6,927
1,453 126.5% 127成
期 業績予想 :Financial forecast for the year ending March 31, 2018
宝ホ
ン
連結
:Takara Holdings Inc. ‐Consolidated‐百万
:Millions of Yen成 期 成 期 成 期 成 期
通期
通期
第 四半期累計第 四半期累計実績
予想
増減
比
実績
予想
増減
比
FY2017 FY2018 Change % FY2017(1Q-2Q)FY2018(1Q-2Q) Change % Actual (a) Forecast (b) (b-a) (b/a) Actual (c) Forecast (d) (d-c) (d/c)
宝酒造
宝酒造 ン
バ
そ 他
調整額
売
高
売
原価
売
総利益
運
費 保管料
広告宣伝費
研究開発費
管理費 そ 他
販売費及び一般管理費
宝酒造
宝酒造 ン
バ
そ 他
調整額
営業利益 △:損失
利息 郤当金
そ 他営業外収益
Other, net
営業外収益
支払利息
そ 他営業外費用
Other, net
営業外費用
経常利益 △:損失
特
利益
特
損失
法人税
民税及び事業税
法人税等調整額
設備投資額
形 無形
減価償却費
形 無形
償却額
対前期
対前期
Change from FY2017 Change from FY2017(1Q-2Q)
149,452
153,000
3,547
102.4%
70,429
71,000
570
100.8%
Takara Shuzo Group
37,540
63,000
25,459
167.8%
15,137
31,000
15,862
Takara Bio Group
ᇞ
21,193
ᇞ
20,200
993
-
ᇞ
9,905
204.8%
Takara Shuzo International Group29,375
33,200
3,824
113.0%
13,199
14,049
849
106.4%
ᇞ
10,049
ᇞ
143
-
Adjustment39,017
39,000
ᇞ
17
100.0%
18,648
234,193
268,000
33,806
114.4%
107,509
125,000
17,490
116.3%
Net sales120.2%
Cost of sales94,010
105,000
10,989
111.7%
43,435
48,000
4,564
110.5%
140,182
163,000
22,817
116.3%
64,073
77,000
12,926
Gross profit
107.7%
Transportation and storage3,198
3,300
101
103.2%
1,505
1,600
94
106.3%
Advertising
8,743
9,600
856
109.8%
4,269
4,600
330
販売
進費 販売
進引当金繰入
34,292
35,400
1,107
103.2%
16,382
16,800
417
102.5%
Sales promotion and allowance for s.p.
5,071
114.6%
Research and development29,673
37,400
7,726
126.0%
13,977
17,900
3,922
128.1%
4,550
5,300
749
116.5%
2,093
2,400
306
Other, net
3,700
517
116.2%
1,393
1,800
406
Takara Bio Group
113.3%
SG&A expenses5,071
5,600
528
110.4%
1,451
1,500
48
103.3%
Takara Shuzo Group
80,458
91,000
10,541
113.1%
38,228
43,300
-
Adjustment13,551
14,000
448
103.3%
5,207
4,700
ᇞ
507
90.3%
Operating income(∆:loss)
ᇞ
72
ᇞ
900
ᇞ
827
-
8
ᇞ
87
ᇞ
95
659
600
ᇞ
59
91.0%
364
300
ᇞ
64
82.3%
Interest and Dividends income
878
600
ᇞ
278
68.3%
366
200
ᇞ
166
54.6%
ᇞ
231
68.4%
Non-operating income481
600
118
124.5%
213
300
86
1,537
1,200
ᇞ
337
78.0%
731
500
140.4%
Interest and discounts expenses262
200
ᇞ
62
76.1%
110
200
89
180.5%
175
154.1%
Non-operating expenses14,344
14,400
55
100.4%
5,614
4,700
ᇞ
914
744
800
55
107.4%
324
500
Extraordinary gain
950
600
ᇞ
350
63.1%
60
83.7%
Ordinary income(∆:loss)1,126
1,400
273
124.3%
21
-
ᇞ
21
-
100
39
166.3%
Extraordinary loss
税金等調整前当期純利益 △:損失
14,520
15,200
679
104.7%
5,575
4,600
ᇞ
975
82.5%
Income(∆:loss) before income taxes
5,208
5,500
216
104.1%
2,321
2,000
ᇞ
82
96.0%
Current income taxes
74
ᇞ
239
Deferred income taxes
当期純利益 △:損失
9,236
9,700
463
105.0%
3,492
2,600
ᇞ
892
74.4%
Net income(∆:loss)
非支郤株主 帰属す 当期純利益 △:損失
755
1,200
444
158.8%
315
200
ᇞ
115
63.4%
Net income attributable to the noncontrolling interest(∆:loss)
75.5%
Net income attributable to owners of the parent
6,658
7,051
392
105.9%
1,909
親会社株主 帰属す 当期純利益 △:損失
8,480
8,500
19
100.2%
3,177
2,400
ᇞ
777
Capital expenditures
3,100
607
124.4%
Depreciation and Amortization5,171
6,600
1,428
127.6%
2,492
19,000
351
101.9%
Other2,167
2,300
132
106.1%
976
1,000
23
102.4%
Other